Breaking News

Cmed Enters Strategic Data Management Services Pact

By Kristin Brooks | March 5, 2014

To provide data capture and management services to support early phase trials

Cmed Group, a full service CRO specializing in complex early phase trials, has entered into a strategic partnership with a top five pharmaceutical company to provide data capture and management services to support their early phase (Phase I, II, Proof of Concept) clinical trial pipeline.
 
Under the three year agreement, Cmed will provide data capture and management using its technologies, and will also collaborate on process and technology innovations to help improve and speed data visibility for critical decision making.
 
Dr. David Connelly, Cmed’s chief executive officer, said, “One of the key drivers for our client was the need for a responsive partner to provide flexible, high quality, efficient services for their fast paced, high throughput early phase pipeline. We are therefore delighted our client chose Cmed to form a strategic partnership so we can develop an already effective and efficient collaboration managing clinical data from our early phase trials into something that is truly smart and world class. We are confident that together, with our existing and emerging technologies and approaches, we can transform the setup, collection, management and review of clinical trial data.”

Related Compliance:

blog comments powered by Disqus
  • Top 25 Pharma and Biopharma Report

    Top 25 Pharma and Biopharma Report

    July 20, 2015
    (Based on 2014 Sales, in $U.S. Millions)

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important